Sign inGet started
Sequence AI Consultant
The peptide formulary, graded by evidence.
Browse 58 peptides synthesized from 280+ peer-reviewed studies — or ask Sequence anything. Every compound carries a GRADE label, and research-only substances are flagged.
Featured peptides
58+
Peptides in formulary
GRADE-graded
280+
Studies synthesized
Peer-reviewed only
9
Goal categories
Recovery to longevity
100%
Evidence-labeled
Every claim
The formulary
Explore by your goal
Filter by focus or search by name, alias or use.
Open any peptide for its mechanism, evidence base and grade.
58 peptides
Research-only peptide notice
Some peptides are research-only substances. BioVise provides evidence summaries for education only — not medical advice. Consult a licensed clinician before starting anything.
Ask Sequence
A peptide consultant
that cites its work
Ask about any compound and Sequence answers with the peer-reviewed evidence, a GRADE label, and an honest read on what's preclinical versus proven in humans.
✓PubMed✓Cochrane✓NEJM✓JAMA✓ClinicalTrials.gov✓Lancet✓Society Guidelines✓National Comprehensive Cancer Network✓And Many More
Never sourced from✕WebMD✕Reddit✕Healthline✕Blogs✕Substack✕Unverified Internet Sources✕Internet Biohackers
Sequence Graded answer
Tirzepatide produced ~20.9% mean body-weight reduction at 72 weeks in SURMOUNT-1 — among the strongest pharmacologic weight-loss results to date. Verified — High
Dual GIP/GLP-1 agonism drives additive appetite and metabolic effects Verified — High
GI side effects are common and usually dose-dependent Verified — Moderate
For educational purposes only. Not a substitute for medical advice.
Ask Sequence your first peptide question.
Browse the full formulary free, then ask Sequence anything — every answer GRADE-labeled and cited.
BioVise is a clinical decision-support tool, not a licensed medical provider.